SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi India informs about board meeting

26 Jul 2023 Evaluate
Sanofi India has informed that the meeting of the Board of Directors of the Company will be held on Thursday, 10th August 2023 to consider the unaudited financial results for the quarter and half year ended 30th June 2023. Further, in reference to letter dated 22nd June 2023 and as per the ‘Sanofi India- Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons', the trading window for the purpose of publication of financial results of the Company for the quarter and half year ended 30th June 2023 shall remain closed from Saturday, 1st July 2023 to Saturday, 12th August 2023.

The above information is a part of company’s filings submitted to BSE.

Sanofi India Share Price

3587.20 8.65 (0.24%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×